Prime Medicine Inc

PRMEStocksBiotechnologyUnited StatesNasdaqUSD

Price

$3.99

Today

+11.5%

YTD

+15.8%

About

Prime Medicine, Inc. is a champion in the biomedical sector, specialising in the development of innovative gene editing therapies. The company operates globally, striving to tackle genetic diseases by targeting the root cause. Prime Medicine, Inc. is a part of the wider medical research and development industry that uses ground-breaking techniques such as base editing to create medical breakthroughs and provide patients with transformative treatments. Prime has also partnered with Beam Therapeutics. Track the share price of PRME by adding it to your eToro watchlist.

Price chart

Closing price history for PRME (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-2.96

P/S (TTM)139.67

P/B (TTM)14.57

Market cap$582.22M

Cap tierSmall-cap

Industry avg P/E-2.16

Profitability

Gross margin-81.64%

EBIT margin-4824.94%

Net margin-3648.96%

ROE-373.29%

ROA-71.16%

Earnings & Revenue

Revenue (TTM)$4.07M

Revenue growth (1Y)-17.9%

EPS (TTM)-$1.09

Free cash flow$-156.85M

Total debt$112.48M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)2.31

Employees146

Next earnings6 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.